Slovick A, Cornet M, Surda P, Tomazic P V
ERS juniors.
Rhinology. 2016 Dec 1;54(4):289-291. doi: 10.4193/Rhin16.404.
Our goal in treating chronic rhinosinusitis (CRS) is to reduce sinonasal symptoms and improve quality of life (QoL). In patients with CRS, sinonasal symptoms have a significant impact on QoL. Various validated measures exist to quantify QoL such as the 22-item Sinonasal Outcomes Test (SNOT- 22) and MSNOT-20 Young Persons Questionnaire (MSYPQ) specific to CRS, while others measure general QoL, such as the EuroQol 5-Dimensional general health-related QoL survey (EQ5D).
我们治疗慢性鼻-鼻窦炎（CRS）的目标是减轻鼻窦症状并改善生活质量（QoL）。在CRS患者中，鼻窦症状对生活质量有显著影响。现有多种经过验证的方法来量化生活质量，如针对CRS的22项鼻窦结局测试（SNOT-22）和MSNOT-20青少年问卷（MSYPQ），而其他一些则测量总体生活质量，如欧洲五维健康相关生活质量调查问卷（EQ5D）。
